KYMAB LIMITED
103Patents
102Active
103Granted
55Portfolio score
Filing activity: Mar 9, 2012 → Jul 30, 2021
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9567399B1 | Antibodies and immunocytokines | Chemistry; Metallurgy | 62 | Active |
| US9617338B1 | Antibodies and immunocytokines | Chemistry; Metallurgy | 61 | Active |
| US9445581B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 46 | Active |
| US8883157B1 | Targeting rare human PCSK9 variants for cholesterol treatment | Chemistry; Metallurgy | 34 | Active |
| US9045545B1 | Precision medicine by targeting PD-L1 variants for treatment of cancer | Chemistry; Metallurgy | 33 | Active |
| US9139653B1 | Anti-human OX40L antibodies and methods of treatment | Chemistry; Metallurgy | 31 | Active |
| US9253965B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 29 | Active |
| US9504236B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 27 | Active |
| US9434782B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 26 | Active |
| US9505827B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 26 | Active |
| US9034332B1 | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment | Chemistry; Metallurgy | 25 | Active |
| US9447177B2 | Transgenic mouse homozygous for chimeric IgH locus | Chemistry; Metallurgy | 25 | Active |
| US9896516B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 20 | Active |
| US9938357B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 20 | Active |
| US9924705B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 20 | Active |
| US9938358B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 19 | Active |
| US9109034B1 | Precision medicine by targeting PD-L1 variants for treatment of cancer | Chemistry; Metallurgy | 18 | Active |
| US9067998B1 | Targeting PD-1 variants for treatment of cancer | Chemistry; Metallurgy | 17 | Active |
| US9783593B2 | Antibodies, variable domains and chains tailored for human use | Chemistry; Metallurgy | 17 | Active |
| US10604576B2 | Antibodies and immunocytokines | Chemistry; Metallurgy | 17 | Active |
| US9788534B2 | Animal models and therapeutic molecules | Chemistry; Metallurgy | 17 | Active |
| US10251377B2 | Transgenic non-human vertebrate for the expression of class-switched, fully human, antibodies | Chemistry; Metallurgy | 16 | Active |
| US9234043B1 | Anti-human OX40L antibodies | Chemistry; Metallurgy | 16 | Active |
| US8945560B1 | Method of treating rheumatoid arthritis using antibody to IL6R | Chemistry; Metallurgy | 15 | Active |
| US9783618B2 | Manipulation of immunoglobulin gene diversity and multi-antibody therapeutics | Chemistry; Metallurgy | 14 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.